Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations.

DiStefano, Michael J; Levy, Joseph F; Odouard, Ilina C; Anderson, Gerard F

DiStefano, Michael J; Levy, Joseph F; Odouard, Ilina C; Anderson, Gerard F.

Afiliación

DiStefano MJ; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Michael.j.distefano@cuanschutz.edu.
Levy JF; Department of Health Policy & Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Odouard IC; Department of Health Policy & Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Anderson GF; Department of Health Policy & Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Value Health ; 26(11): 1618-1624, 2023 11.

Article en En | MEDLINE | ID: mdl-37689264

Asunto(s)

Medicare; Negociación; Anciano; Estados Unidos; Humanos; Costos de los Medicamentos; Costos y Análisis de Costo

Palabras clave

Inflation Reduction Act; Medicare; added therapeutic benefit; comparative effectiveness; drug price negotiation; health technology assessment; therapeutic reference pricing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Medicare / Negociación Tipo de estudio: Guideline / Health_economic_evaluation / Health_technology_assessment Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google